Science Advocates Frustrated by President’s Budget

Congress is not expected to fully enact the proposed cuts to research and public health programs.

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ISTOCK, LUCIDOLOGYPresident Donald Trump unveiled details of his latest 2018 budget proposal today (May 23), and the scientific community—while not entirely surprised—was frustrated by what it read. The National Institutes of Health (NIH) would receive $25.9 billion, a more than $7 billion drop from 2017 funding. The NIH’s Fogarty International Center, which focuses on developing countries, would be eliminated, and the Agency for Healthcare Research and Quality would be folded into other NIH programs.

“The Budget eliminates programs that are duplicative or have limited impact on public health and well-being,” according to the document, entitled America First: A Budget Blueprint to Make America Great Again.

Researchers and science advocates had a different take. “It is a devastating budget, there’s no way around it,” Benjamin Corb, the director of public affairs at the American Society for Biochemistry and Molecular Biology, told The Scientist. “A 22 percent cut to the NIH makes it a near impossibility for the NIH to even fund a new research grant in the next fiscal year.”

“The president’s proposed FY18 budget is an imbalanced, heavy-handed approach to bolstering national defense at the expense of other American priorities, including the research and innovation crucial to national security,” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies